
Aerie Pharmaceuticals AERI
Quartalsbericht 2022-Q3
hinzugefügt 23.12.2023
Aerie Pharmaceuticals EBITDA per Share 2011-2026 | AERI
EBITDA per Share Jährlich Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.86 | -3.25 | -4.01 | -4.98 | -4.08 | -3.29 | -2.9 | -2.07 | -4.46 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.86 | -4.98 | -3.32 |
EBITDA per Share Vierteljährlich Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.56 | -0.38 | -0.67 | - | -0.7 | -0.68 | -0.71 | - | -0.63 | -0.86 | -0.92 | - | -0.87 | -0.97 | -1.05 | - | -1.37 | -1.39 | -1.04 | - | -0.86 | -0.78 | -0.74 | -0.86 | -0.77 | -0.83 | -0.82 | -0.75 | -0.66 | -0.7 | -0.8 | -0.67 | -0.54 | -0.49 | -0.38 | -0.69 | -13 | -12 | -9.29 | -7 | -5.79 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.38 | -13 | -1.98 |
EBITDA per Share anderer Aktien in der Arzneimittelhersteller
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
-1.16 | - | 7.5 % | $ 6.35 M | ||
|
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | ||
|
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.07 | -0.47 % | $ 115 M | ||
|
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | ||
|
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M | ||
|
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | ||
|
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | ||
|
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | ||
|
Harrow Health
HROW
|
0.87 | $ 38.95 | -27.32 % | $ 1.43 B | ||
|
Cronos Group
CRON
|
-0.504 | $ 2.62 | -0.57 % | $ 1.36 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B | ||
|
Jupiter Wellness
JUPW
|
0.01 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
-0.11 | $ 0.55 | -0.97 % | $ 9.61 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 4.5 | -7.02 % | $ 63.3 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
-106 | - | - | $ 193 M | ||
|
Aurora Cannabis
ACB
|
-1.67 | $ 3.52 | -5.26 % | $ 86.3 M | ||
|
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | ||
|
Organogenesis Holdings
ORGO
|
0.09 | $ 2.86 | -4.67 % | $ 377 M | ||
|
Emergent BioSolutions
EBS
|
-11.7 | $ 8.87 | -1.33 % | $ 454 M | ||
|
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
-3.03 | $ 11.92 | 1.24 % | $ 847 M | ||
|
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
-0.22 | $ 0.9 | 0.37 % | $ 21 M | ||
|
Evolus
EOLS
|
-0.39 | $ 4.21 | -1.86 % | $ 261 M | ||
|
Bausch Health Companies
BHC
|
6.1 | $ 5.77 | -3.11 % | $ 2.11 B | ||
|
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | ||
|
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | ||
|
OrganiGram Holdings
OGI
|
-0.36 | $ 1.38 | -3.17 % | $ 402 M | ||
|
Perrigo Company plc
PRGO
|
-5.67 | $ 11.38 | -7.97 % | $ 1.58 B | ||
|
Sundial Growers
SNDL
|
-71 | $ 1.53 | 0.33 % | $ 3.37 M | ||
|
Pacira BioSciences
PCRX
|
0.12 | $ 22.06 | 3.67 % | $ 1.02 B | ||
|
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | ||
|
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | ||
|
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
-3.45 | $ 4.67 | -3.51 % | $ 141 M | ||
|
SCYNEXIS
SCYX
|
1.53 | $ 0.73 | -2.19 % | $ 34.9 M | ||
|
Solid Biosciences
SLDB
|
-3.12 | $ 5.99 | -3.47 % | $ 244 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 2.76 | -2.66 % | $ 3.43 M | ||
|
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | ||
|
TherapeuticsMD
TXMD
|
-0.73 | $ 2.26 | 1.0 % | $ 23.6 M | ||
|
Tilray
TLRY
|
-2.22 | $ 7.37 | -2.97 % | $ 4.55 B | ||
|
Veru
VERU
|
-0.27 | $ 2.54 | -3.05 % | $ 343 M | ||
|
Viatris
VTRS
|
2.92 | $ 15.09 | -3.89 % | $ 18.1 B | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M | ||
|
cbdMD
YCBD
|
-0.66 | $ 0.79 | -2.48 % | $ 3.41 M |